Qosina and Resolution Medical partner to produce COVID-19 test swab

Qosina has announced it now carries a sterile 3D-printed nasopharyngeal COVID-19 testing swab for nasal mucosa specimen collection. 

Developed by Resolution Medical, an in vitro diagnostic and medical device manufacturer, the 3D-printed sterile swab is a cost-effective alternative to the traditional, flocked nasopharyngeal swab.

It is produced quickly by using already-existing, industry-approved materials and the Carbon Digital Light Synthesis (Carbon DLS) 3D printing process. The swab is 5.9 inches in length, and the swab head features a soft, lattice-style cage around a flexible helical core, allowing the swab to more easily conform to the organic pathway of the nasal cavity. This sterile swab comes individually packaged and has a shelf life of six months.

Scott Herskovitz, president and CEO of Qosina, said: “As a leader in swabs provided to the medical industry, we are excited to add the 3D-printed swab to our product offering. Its creative design meets the growing demand from our customers for high quality COVID-19 testing swabs. Our mission is to provide the best customer experience possible by helping our customers find, order and receive quality medical components quickly and accurately, and this partnership is the perfect fit to support our mission.”